INTERNATIONAL PATENT: MODULATION THERAPEUTICS, INC., QUEEN MARY UNIVERSITY OF LONDON, HAZLEHURST, LORI, GALLIPOLI, PAOLO, DEMBITZ, VILMA TOMIC FILES APPLICATION FOR "SCD1 INHIBITORS FOR TREATING HEMATOLYMPHOID NEOPLASMS"

GENEVA, Jan. 28 -- MODULATION THERAPEUTICS, INC. (40 High StreetMorgantown, West Virginia 26505), QUEEN MARY UNIVERSITY OF LONDON (Mile End RoadLondon Middlesex E1 4NS), HAZLEHURST, Lori (c/o Modulation Therapeutics, Inc.40 High StreetMorgantown, West Virginia 26505), GALLIPOLI, Paolo (4 Kinsman WayCambridge Cambridgeshire CB2 9FX), DEMBITZ, Vilma Tomic (Hvarska 1110 000 Zagreb) filed a patent application (PCT/US2024/037898) for "SCD1 INHIBITORS FOR TREATING HEMATOLYMPHOID NEOPLASMS" on Jul 12, 2024. With publication no. WO/2025/019361, the details related to the patent application was published on Jan 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the...